Ocrelizumab

Records for this ingredient, by country (identity only).

ATC L04AG08 · 10 markets · 21 records

Ocrelizumab 10 markets · 21 records Forms

Filters

MarketAU 5 GB 3 US 2 SG 2 FR 2 CA 1 ES 1 MX 1 HK 1 EU 1

Kind

Strength

AU 5 records · 4 shown of 4 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

920 mg/23 mLinjectionOCREVUS SC also in GB·SG·FR
300 mg/10 mLinjectionOCREVUS also in GB·US·SG
300 mg per mL / per unit basis not statedinjectionOCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial unknown
920 mg per mL / per unit basis not statedinjectionOCREVUS SC ocrelizumab 920 mg/23 mL solution for injection vial unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名OCREVUS ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 3 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

920 mg/23 mLinjectionOcrevus 920mg/23ml solution for injection vials also in AU·SG·FR
300 mg/10 mLinjectionOcrevus 300mg/10ml concentrate for solution for infusion vials also in AU·US·SG

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

300 mg/10 mLinjectionOCREVUS also in AU·GB·SG

Combination products containing this ingredient

920 mg/23 mLinjection CombinationHyaluronidase (Human Recombinant) 23,000 unit/23 mL + Ocrelizumab 920 mg/23 mLOcrevus Zunovo

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

920 mg/23 mLinjectionOCREVUS SOLUTION FOR INJECTION 920MG/23ML also in AU·GB·FR
300 mg/10 mLinjectionOCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML also in AU·GB·US

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

920 mg/23 mLinjectionOCREVUS 920 mg, solution injectable also in AU·GB·SG
300 mg per mL / per unit basis not statedinjectionOCREVUS 300 mg, solution à diluer pour perfusion

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

30 mg per mL / per unit basis not statedliquidOCREVUS

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

Only this ingredient

300 mg per mL / per unit basis not statedinjectionOCREVUS

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名OCREVUS SC ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名OCREVUS ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	HK	EU	FR
920 mg/23 mL injection	not recorded	Ocrevus 920mg/23ml solution for injection vials	not recorded	OCREVUS SC	OCREVUS SOLUTION FOR INJECTION 920MG/23ML	not recorded	not recorded	not recorded	not recorded	OCREVUS 920 mg, solution injectable
300 mg/10 mL injection	OCREVUS	Ocrevus 300mg/10ml concentrate for solution for infusion vials	not recorded	OCREVUS	OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial	not recorded	OCREVUS	not recorded	not recorded	not recorded	OCREVUS 300 mg, solution à diluer pour perfusion
30 mg per mL / per unit basis not stated cannot compare liquid	not recorded	not recorded	OCREVUS	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
920 mg per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	OCREVUS SC ocrelizumab 920 mg/23 mL solution for injection vial	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
920 mg/23 mL Combination Hyaluronidase (Human Recombinant) 23,000 unit/23 mL + Ocrelizumab 920 mg/23 mL injection	Ocrevus Zunovo	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	OCREVUS	not recorded	not recorded	not recorded	OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML	OCREVUS	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	OCREVUS SC	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · MX and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · MX que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · MX 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.